Chemosensitization of tumor cells: Inactivation of nuclear factor-kappa B associated with chemosensitivity in melanoma cells after combination treatment with E2F-1 and doxorubicin

Methods in Molecular Biology

Volumn 542, Issue , 2009, Pages 301-313

  Hao, Hongying ^a   Zhou, H Sam ^a   McMasters, Kelly M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Apoptosis; doxorubicin; E2F 1; electrophoretic mobility shift assay (EMSA); nuclear factor B (NF B)

Indexed keywords

DNA; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; TRANSCRIPTION FACTOR E2F1;

ARTICLE; DRUG SCREENING; GEL MOBILITY SHIFT ASSAY; GENE SILENCING; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; MELANOMA; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PLASMID; PROTEIN BINDING; REPORTER GENE; TUMOR CELL LINE;

CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DNA; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; E2F1 TRANSCRIPTION FACTOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE SILENCING; GENE THERAPY; GENES, REPORTER; HUMANS; LUCIFERASES; MELANOMA; NF-KAPPA B; PLASMIDS; PROTEIN BINDING; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 67650321537     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-561-9_16     Document Type: Article

References (16)

1. Verweij , J. and de Jonge , M.J.2000) Achievements and future of chemotherapy. Eur. J. Cancer 36 , 1479-1487
2. Liem , A.A. , Chamberlain , M.P. , Wolf. C.R. , and Thompson , A.M.2002) The role of signal transduction in cancer treatment and drug resistance Eur. J. Surg. Oncol. 28 , 679-684
3. Meng , R.D. , Phillips , P. , and El-Deiry , W.S.1999) p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin Int. J. Oncol. 14 , 5-14
4. Cheon , J. , Ko , S.C. , Gardner , T.A. , Shirakawa , T. , Gotoh , A. , Kao , C. , and Chung L.W.1997) Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model Cancer Gene. Ther 4 , 359-365
5. Nemunaitis , J. , Swisher , S.G. , Timmons , T. , Connors , D. , Mack , M. , Doerksen , L. , Weill , D. , Wait , J. , Lawrence , D.D. , Kemp , B.L. , Fossella , F. , Glisson , B.S. , Hong , W.K. , Khuri , F.R. , Kurie , J.M. , Lee , J.J. Lee , J.S. , Nguyen , D.M. , Nesbitt , J.C. , Perez-Soler , R. , Pisters , K.M.W. , Putnam , J.B. , Richli , W.R. , Shin , D.M. , Walsh , G.L. , Merritt , J. , and Roth , J.2000) Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer J. Clin. Oncol 18 , 609-622
6. Yeh , P.Y. , Chuang , S.E. , Yeh , K.H. , Song , Y.C. , Ea , C.K. , and Cheng , A.L.2002) Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF- B activation Biochem. Pharmacol 63 , 1423-1430
7. Yeh , P.Y. , Chuang , S.E. , Yeh , K.H. , Song , Y.C. , and Cheng , A.L.2003) Involvement of nuclear transcription factor- B in lowdose doxorubicininduced drug resistance of cervical carcinoma cells Biochem. Pharmacol 66 , 25-33
8. Karin , M.2006) Nuclear factor-kappaB in cancer development and progression Nature 441 (7092) , 431-436
9. Ghosh , S. and Karin , M.2002) Missing pieces in the NF- B puzzle Cell , 109 (Suppl.) , S81-S96
10. Rothwarf, D.M. and Karin, M.1999) The NF- B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci. STKE (October 26) 1999 (5), RE1.
11. Karin , M. and Ben-Neriah , Y.2000) Phosphorylation meets ubiquitination: the control of NF- B activity Annu. Rev. Immunol 18 , 621-663
12. Werner , S.L. , Barken , D. and Hoffmann , A.2005) Stimulus specificity of gene expression programs determined by temporal control of IKK activity Science 309 , 1857-1861
13. Park , J.M. , Greten , F.R. , Wong , A. , Westrick , R.J. , Arthur , S.C. , Otsu , K. , Hoffmann , A. , Montminy , M. and Karin , M.2005) Signaling pathways and genes that inhibit pathogen- induced macrophage apoptosis: CREB and NF- B as key regulators Immunity 23 , 319-329
14. Covert , M.W. , Leung , T.H. , Gaston , J.E. and Baltimore , D.2005) Achieving stability of lipopolysaccharide-induced NF- B activation Science 309 , 1854-1857
15. Aggarwal , B.B.2004) Nuclear factor- B: the enemy within Cancer Cell 6 , 203-208
16. Hao , H. , Dong , Y.B. , Bowling , M.T. , Zhou , H.S. and McMasters , K.M.2006) Alteration of gene expression in melanoma cells following combined treatment with E2F-1 and adriamycin Anticancer Res 26 (3A) , 1947-1956